The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Characterization of Growth Factor-binding Structures in Heparin/Heparan Sulfate Using an Octasaccharide Library
Open accessAbstract
Heparan sulfate (HS) chains interact with various growth and differentiation factors and morphogens, and the most interactions occur on the specific regions of the chains with certain monosaccharide sequences and sulfation patterns. Here we generated a library of octasaccharides by semienzymatic methods by using recombinant HS 2-O-sulfotransferase and HS 6-O-sulfotransferase, and we have made a systematic investigation of the specific binding structures for various heparin-binding growth factors. An octasaccharide (Octa-I, DeltaHexA-GlcNSO(3)-(HexA-GlcNSO(3))(3)) was prepared by partial heparitinase digestion from completely desulfated N-resulfated heparin. 2-O- and 6-O-sulfated Octa-I were prepared by enzymatically transferring one to three 2-O-sulfate groups and one to three 6-O-sulfate groups per molecule, respectively, to Octa-I. Another octasaccharide containing 3 units of HexA(2SO(4))-GlcNSO(3)(6SO(4)) was prepared also from heparin. This octasaccharide library was subjected to affinity chromatography for interactions with fibroblast growth factor (FGF)-2, -4, -7, -8, -10, and -18, hepatocyte growth factor, bone morphogenetic protein 6, and vascular endothelial growth factor, respectively. Based upon differences in the affinity to those octasaccharides, the growth factors could be classified roughly into five groups: group 1 needed 2-O-sulfate but not 6-O-sulfate (FGF-2); group 2 needed 6-O-sulfate but not 2-O-sulfate (FGF-10); group 3 had the affinity to both 2-O-sulfate and 6-O-sulfate but preferred 2-O-sulfate (FGF-18, hepatocyte growth factor); group 4 required both 2-O-sulfate and 6-O-sulfate (FGF-4, FGF-7); and group 5 hardly bound to any octasaccharides (FGF-8, bone morphogenetic protein 6, and vascular endothelial growth factor). The approach using the oligosaccharide library may be useful to define specific structures required for binding to various heparin-binding proteins. Octasaccharides with the high affinity to FGF-2 and FGF-10 had the activity to release them, respectively, from their complexes with HS. Thus, the library may provide new reagents to specifically regulate bindings of the growth factors to HS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D. E., & Vlodavsky, I. (1988) · PubMed · Cited by 969
Formation of anhydrosugars in the chemical depolymerization of heparin
Shively, J. E., & Conrad, H. E. (1976) · Biochemistry · doi:10.1021/bi00663a005 · Cited by 901
Role of morphogenetic proteins in skeletal tissue engineering and regeneration
Reddi, A. H. (1998) · Nature Biotechnology · doi:10.1038/nbt0398-247 · Cited by 832
Self-citationHeparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., & Yayon, A. (1994) · Cell · doi:10.1016/0092-8674(94)90031-0 · Cited by 536
Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.
Turnbull, J. E., Fernig, D. G., Ke, Y., Wilkinson, M. C., & Gallagher, J. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50023-0 · Cited by 514
(1998) · Elsevier eBooks · doi:10.1016/b978-0-12-186060-8.x5000-1 · Cited by 508
Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U., & Rapraeger, A. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80471-2 · Cited by 481
Cited by
Interactions between heparan sulfate and proteins: the concept of specificity
Kreuger, J., Spillmann, D., Li, J.-P., & Lindahl, U. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604035 · Cited by 449
Heparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410
Engineering growth factors for regenerative medicine applications
Mitchell, A. C., Briquez, P. S., Hubbell, J. A., & Cochran, J. R. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.007 · Cited by 372
Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
Zieris, A., Prokoph, S., Levental, K. R., Welzel, P. B., Grimmer, M., Freudenberg, U., & Werner, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.021 · Cited by 209
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., Luscieti, S., Nai, A., & Arosio, P. (2011) · Blood · doi:10.1182/blood-2010-06-289082 · Cited by 148
Heparan sulfate proteoglycans: a sugar code for vertebrate development?
Poulain, F. E., & Yost, H. J. (2015) · Development · doi:10.1242/dev.098178 · Cited by 139
Chondroitin sulfates and their binding molecules in the central nervous system
Djerbal, L., Lortat-Jacob, H., & Kwok, J. (2017) · Glycoconjugate Journal · doi:10.1007/s10719-017-9761-z · Cited by 144
Habuchi, H., Nagai, N., Sugaya, N., Atsumi, F., Stevens, R. L., & Kimata, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607434200 · Cited by 139
Self-citationAwada, H. K., Johnson, N. R., & Wang, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.034 · Cited by 138
Polysaccharide matrices used in 3D in vitro cell culture systems
Diekjürgen, D., & Grainger, D. W. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.020 · Cited by 125
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie, A., Takami, M., Kubo, H., Sekino-Suzuki, N., Kasahara, K., & Sanai, Y. (2007) · Bone · doi:10.1016/j.bone.2007.04.190 · Cited by 116
“2-O-Sulfates of heparin are, however, required for the interaction between heparin and VEGF [41], suggesting that VEGF is not involved in the heparin-induced osteoclastic bone resorption in the coculture.”
BackgroundComparison of the Interactions of Different Growth Factors and Glycosaminoglycans
Zhang, F., Zheng, L., Cheng, S., Peng, Y., Fu, L., Zhang, X., & Linhardt, R. (2019) · Molecules · doi:10.3390/molecules24183360 · Cited by 93
The Structural Biology of the FGF19 Subfamily
Beenken, A., & Mohammadi, M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0887-1_1 · Cited by 93
Auxiliary and Autonomous Proteoglycan Signaling Networks
Elfenbein, A., & Simons, M. (2010) · Methods in Enzymology · doi:10.1016/s0076-6879(10)80001-1 · Cited by 32
Chemistry and Function of Glycosaminoglycans in the Nervous System
Schwartz, N. B., & Domowicz, M. S. (2014) · Advances in Neurobiology · doi:10.1007/978-1-4939-1154-7_5 · Cited by 25
Metadata
- Authors
- Ashikari-Hada, S., Habuchi, H., Kariya, Y., Itoh, N., Reddi, A. H., & Kimata, K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 13
- Pages
- 12346-12354
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2116715149
- Cited by
- 296
- References
- 49
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.